PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7691323-0	1993	Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.	mafosfamide	48-59	KIT ligand	Homo sapiens	28-44	
7691323-2	1993	It was the aim of the present study to investigate the capability of recombinant human stem cell factor (SCF) in combination with other growth factors to support the in vitro growth of mafosfamide-treated progenitor cells such as mixed colony forming units (CFU-GEMM), erythroid burst forming units (BFU-E) and granulocyte-macrophage CFU (CFU-GM).	mafosfamide	185-196	KIT ligand	Homo sapiens	87-103	
7691323-2	1993	It was the aim of the present study to investigate the capability of recombinant human stem cell factor (SCF) in combination with other growth factors to support the in vitro growth of mafosfamide-treated progenitor cells such as mixed colony forming units (CFU-GEMM), erythroid burst forming units (BFU-E) and granulocyte-macrophage CFU (CFU-GM).	mafosfamide	185-196	KIT ligand	Homo sapiens	105-108	
7691323-5	1993	SCF induces a dose-dependent, statistically significant enhancement of colony formation by CD34+, mafosfamide-treated cells.	mafosfamide	98-109	KIT ligand	Homo sapiens	0-3	
7691323-6	1993	As shown by single colony transfer experiments, mafosfamide-resistant clones promoted by SCF have a significantly higher replating capacity as compared with mafosfamide-resistant clones grown without SCF.	mafosfamide	48-59	KIT ligand	Homo sapiens	89-92	
7691323-6	1993	As shown by single colony transfer experiments, mafosfamide-resistant clones promoted by SCF have a significantly higher replating capacity as compared with mafosfamide-resistant clones grown without SCF.	mafosfamide	48-59	KIT ligand	Homo sapiens	200-203